Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04887870
Title Study of Sitravatinib With or Without Other Anticancer Therapies Receiving Clinical Benefit From Parent Study
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Mirati Therapeutics Inc.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Local Institution - 516-014-021 Littleton Colorado 80218 United States Details
Local Institution - 516-014-029 Goshen Indiana 46526 United States Details
Local Institution - 516-014-002 Boston Massachusetts 02215 United States Details
Local Institution - 516-014-014 Detroit Michigan 48201 United States Details
Local Institution - 516-014-005 Minneapolis Minnesota 55455 United States Details
Local Institution - 516-014-018 Omaha Nebraska 68130 United States Details
Local Institution - 516-014-011 Albany New York 12208 United States Details
Local Institution - 516-014-016 New York New York 10065 United States Details
Local Institution - 516-014-004 Columbus Ohio 43210 United States Details
Local Institution - 516-014-001 Austin Texas 78758 United States Details
Local Institution - 516-014-006 Denison Texas 75020 United States Details
Local Institution - 516-014-013 Houston Texas 77030 United States Details
Local Institution - 516-014-027 Fairfax Virginia 22031 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field